Preview Mode Links will not work in preview mode

Angel Invest Boston


Sep 21, 2022

Angel Scale Biotech: Learn More

Yun Rhie, Minwoo Jung, and Minjun Kim are the founders of WittGen. The company is working with AI to create a more efficient platform for treating cancer, a field which tends to have a lower treatment success rate due to its complexity.

Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish and Richardson.

Highlights:

  • Sal Daher Introduces Yun Rhie, Minwoo Jung, and Minjun Kim
  • "... The problem you have is that you have to figure out what kind of a tumor you have in order to treat it, to have the right medication to treat it...."
  • Looking Ahead at What's to Come for WittGen
  • "... Using sequencing of the RNA, which tells you what genes are being expressed and being triggered, and then you can look at that and then compare that to samples of the cells, looked at in the microscope and so on..."
  • What Sets WittGen Apart
  • How the Team Came to Be

Topics: robotics/AI, biotech, founding stories